CTRI/2022/12/048262
Not yet recruiting
Phase 4
Evaluation of the effect of systemically administered melatonin in patients undergoing regenerative surgical periodontal therapy- a double blind placebo controlled clinical trial
Other self0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: M278- Other specified diseases of jaws
- Sponsor
- Other self
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.systemically healthy Subjects with periodontal disease indicated for flap surgery
- •2\. Subjects with three/two walled intrabony defects that can be regenerated
Exclusion Criteria
- •1\. Subjects without periodontal disease
- •2\. Subjects with periodontal disease not requiring regenerative therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
sefullness of Systemically and Locally Delivered Licorice Adjunct to Scaling in Chronic Periodontitis PatientsHealth Condition 1: M272- Inflammatory conditions of jawsCTRI/2019/01/016850Dr Sayali Chandrakant Patil
Not yet recruiting
Phase 3
Triphala for bleeding gumsHealth Condition 1: M95- Other acquired deformities of musculoskeletal system and connective tissueCTRI/2019/12/022518Dr Gayathri R
Not yet recruiting
Phase 3
Effects of Babul mouthwash and capsules containing Babul extract on the gum health in patients suffering from pyorrhea (bleeding and swollen gums)Health Condition 1: K053- Chronic periodontitisCTRI/2024/04/066318Rosmy Davis Vadekethala
Active, not recruiting
Phase 1
Evaluation of the efficacy and safety of administering lidocaine spray in gastroscopies: A randomized clinical trial.Elective gastroscopyMedDRA version: 18.0 Level: LLT Classification code 10018047 Term: Gastroscopy System Organ Class: 100000004848Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]EUCTR2015-000923-10-ESBASQUE HEALTH SYSTEM552
Not yet recruiting
Phase 2
systemic and intratympanic corticosteroid treatment in sensorineural hearing losssudden sensorineural hearing loss.Unspecified sensorineural hearing lossH90.5IRCT20230721058871N1Esfahan University of Medical Sciences40